BRCA1 and ovarian cancer: In some cases, tumors exploited NMD by positively selecting for nonsense mutations to downregulate tumor suppressor genes, as has been shown for BRCA1 and BRCA2, which were associated with inherited susceptibility and platinum resistance in ovarian cancer [39–43].